Regza Plus 0.5/10 Tablet 10's Substitute
Edoc Life Sciences Pvt Ltd
₹106.5
(₹10.65 per unit)
D D Pharmaceuticals Pvt Ltd
₹133.5
(₹13.35 per unit)
Mankind Pharma Pvt Ltd
₹170
(₹17.0 per unit)
Alteus Biogenics Pvt Ltd
₹265
(₹17.67 per unit)
Salas Pharmaceuticals
₹270
(₹18.0 per unit)
Shine Pharmaceuticals Ltd
₹295
(₹19.67 per unit)
Ipca Laboratories Ltd
₹297
(₹19.8 per unit)
Alkem Laboratories Ltd
₹199.5
(₹19.95 per unit)
Sun Pharmaceutical Industries Ltd
₹200
(₹20.0 per unit)
Intas Pharmaceuticals Ltd
₹306
(₹20.4 per unit)
Intas Pharmaceuticals Ltd
₹306
(₹20.4 per unit)
Torrent Pharmaceuticals Ltd
₹320
(₹21.33 per unit)
Torrent Pharmaceuticals Ltd
₹330.5
(₹22.03 per unit)
Lupin Ltd
₹373
(₹24.87 per unit)
Abbott India Ltd
₹379
(₹25.27 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Regza Plus 0.5/10 Tablet 10's to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - CLONAZEPAM-0.5MG+ESCITALOPRAM-10MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Regza Plus 0.5/10 Tablet 10's is used to manage anxiety disorders, panic attacks, and depression. The detailed uses of Regza Plus 0.5/10 Tablet 10's are as follows:
Regza Plus 0.5/10 Tablet 10's helps support mental wellbeing by addressing symptoms of anxiety and mood-related conditions. By combining complementary active ingredients, it promotes emotional balance, reduces distressing symptoms, and helps improve day-to-day functioning.
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX